-
VRCA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Verrica Pharmaceuticals (VRCA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 22.96 mm | 22.96 mm | 22.96 mm | 22.96 mm | 22.96 mm | 22.96 mm |
Cash burn (monthly) | 2.99 mm | 5.11 mm | 6.90 mm | 6.47 mm | 2.85 mm | 4.95 mm |
Cash used (since last report) | 12.03 mm | 20.58 mm | 27.77 mm | 26.04 mm | 11.48 mm | 19.91 mm |
Cash remaining | 10.92 mm | 2.38 mm | -4.82 mm | -3.08 mm | 11.48 mm | 3.05 mm |
Runway (months of cash) | 3.7 | 0.5 | -0.7 | -0.5 | 4.0 | 0.6 |
13F holders | Current |
---|---|
Total holders | 81 |
Opened positions | 21 |
Closed positions | 14 |
Increased positions | 24 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 21.12 bn |
Total shares | 16.38 mm |
Total puts | 6.50 k |
Total calls | 9.90 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
Perceptive Advisors | 7.10 mm | $10.29 bn |
Paul B Manning | 1.48 mm | $3.70 mm |
Vanguard | 1.29 mm | $1.87 bn |
BlackRock | 1.09 mm | $1.57 bn |
FMR | 634.31 k | $919.75 mm |
STT State Street | 512.82 k | $743.59 mm |
Geode Capital Management | 455.48 k | $660.52 mm |
Propel Bio Management | 344.94 k | $500.16 mm |
Qube Research & Technologies | 322.19 k | $467.17 mm |
XTX Topco | 231.15 k | $335.17 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Dec 24 | David Zawitz | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.95 | 950,000 | 902.50 k | 950,000 |
26 Nov 24 | Paul B Manning | Common Stock | Gift | Dispose G | No | No | 0 | 450,000 | 0.00 | 25,828,094 |
26 Nov 24 | Jayson Rieger | Common Stock | Gift | Acquire G | No | No | 0 | 50,000 | 0.00 | 882,826 |
26 Nov 24 | Sean Stalfort | Common Stock | Gift | Acquire G | No | No | 0 | 50,000 | 0.00 | 1,873,800 |
22 Nov 24 | Paul B Manning | Common Stock | Buy | Acquire P | Yes | No | 0 | 4,494,382 | 0.00 | 5,976,101 |
22 Nov 24 | Paul B Manning | Common Stock | Buy | Acquire P | No | No | 0 | 18,426,966 | 0.00 | 26,278,094 |
22 Nov 24 | Paul B Manning | Series B Warrants Common Stock | Buy | Acquire P | Yes | No | 1.335 | 2,247,191 | 3.00 mm | 2,247,191 |
22 Nov 24 | Paul B Manning | Series A Warrants Common Stock | Buy | Acquire P | Yes | No | 1.068 | 2,247,191 | 2.40 mm | 2,247,191 |
22 Nov 24 | Paul B Manning | Series B Warrants Common Stock | Buy | Acquire P | No | No | 1.335 | 9,213,483 | 12.30 mm | 9,213,483 |
22 Nov 24 | Paul B Manning | Series A Warrants Common Stock | Buy | Acquire P | No | No | 1.068 | 9,213,483 | 9.84 mm | 9,213,483 |